Phylogix Inc. is a biotechnology company focused on tissue protection and oncology. The company develops lectin-based drugs focused on tissue protection, oncology, and immunology. It also involves in the development of FRIL, an agent to protect patients from the toxic side-effects of chemotherapy.

Phylogix Inc. is based in Scarborough, Maine.

Patents show all

1Applications

Overview

Total FundingEmployeesLast Funding DateStatus
$15,000,000unknown2004-03-10Closed

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2001-11-04$3,000,000Series ABiotechnology Value FundMaine Venture Fund
2004-03-10$12,000,000Series BAtlas Venture, Prospect Venture PartnersRadius Ventures, Canaan Partners, Biotechnology Value Fund